FDA extends comment period on trans-fat labeling
The Food and Drug Administration on March 1 extended the comment period for proposed rulemaking on trans-fat labeling until June 18 and scheduled a Food Advisory Committee Nutrition Subcommittee meeting for April 27 and 28. The outcome of this meeting may help determine the course of action for trans-fat labeling. For more information, see the Federal Register of July 11, 2003 (68 FR 41507) and April 19, 2004 (69 FR 20838-20839).